Related references
Note: Only part of the references are listed.In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
Maria Teresa Di Martino et al.
PLOS ONE (2014)
Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora-B
Ping Liu et al.
FEBS LETTERS (2013)
Targeting long non-coding RNAs in cancers: Progress and prospects
Chi Han Li et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Efficient drug-delivery using magnetic nanoparticles - biodistribution and therapeutic effects in tumour bearing rabbits
Rainer Tietze et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Hui Ling et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer
K. Kim et al.
ONCOGENE (2013)
Whole-Genome Thermodynamic Analysis Reduces siRNA Off-Target Effects
Xi Chen et al.
PLOS ONE (2013)
First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
Josep Tabernero et al.
CANCER DISCOVERY (2013)
Small interfering RNA-based molecular therapy of cancers
Wei Guo et al.
CHINESE JOURNAL OF CANCER (2013)
Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment
Pedro M. Costa et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
RNAi-mediated gene silencing in cancer therapy
Wei-Qiong Yang et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model
Elisa Callegari et al.
HEPATOLOGY (2012)
Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors
Dirk Strumberg et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2012)
Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition
Liang Ying et al.
MOLECULAR BIOSYSTEMS (2012)
Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation
Ming-chun Lai et al.
MEDICAL ONCOLOGY (2012)
A Genetic Variant in Long Non-Coding RNA HULC Contributes to Risk of HBV-Related Hepatocellular Carcinoma in a Chinese Population
Yao Liu et al.
PLOS ONE (2012)
High Interstitial Fluid Pressure Is Associated with Low Tumour Penetration of Diagnostic Monoclonal Antibodies Applied for Molecular Imaging Purposes
Markus Heine et al.
PLOS ONE (2012)
Overexpression of Long Non-coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation
Zhe Yang et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival
Jong-Kook Park et al.
CANCER RESEARCH (2011)
Cyclodextrin-based gene delivery systems
Carmen Ortiz Mellet et al.
CHEMICAL SOCIETY REVIEWS (2011)
Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung
Melanie Guenther et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Large Intervening Non-coding RNA HOTAIR is Associated with Hepatocellular Carcinoma Progression
Y. J. Geng et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth
Lars Henning Schmidt et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia
Hua Zhang et al.
MOLECULAR CANCER (2011)
The functional role of long non-coding RNA in human carcinomas
Ewan A. Gibb et al.
MOLECULAR CANCER (2011)
siRNA Off-Target Effects Can Be Reduced at Concentrations That Match Their Individual Potency
Daniel R. Caffrey et al.
PLOS ONE (2011)
Long noncoding RNAs in cell biology
Michael B. Clark et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
Long noncoding RNAs and human disease
Orly Wapinski et al.
TRENDS IN CELL BIOLOGY (2011)
Unity and diversity in the human adenoviruses: exploiting alternative entry pathways for gene therapy
Kathryn Hall et al.
BIOCHEMICAL JOURNAL (2010)
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells
Y. Tomimaru et al.
BRITISH JOURNAL OF CANCER (2010)
Long Noncoding RNAs with Enhancer-like Function in Human Cells
Ulf Andersson Orom et al.
CELL (2010)
Multifunctional nanocomplexes for gene transfer and gene therapy
Stephen L. Hart
CELL BIOLOGY AND TOXICOLOGY (2010)
MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes
Keiko Tano et al.
FEBS LETTERS (2010)
Large non-coding RNAs: missing links in cancer?
Maite Huarte et al.
HUMAN MOLECULAR GENETICS (2010)
Adeno-associated virus-delivered short hairpin-structured RNA for androgen receptor gene silencing induces tumor eradication of prostate cancer xenografts in nude mice: a preclinical study
Aijing Sun et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Biodegradable dextran nanogels as functional carriers for the intracellular delivery of small interfering RNA
K. Raemdonck et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Development of a highly stable and targetable nanoliposomal formulation of topotecan
Daryl C. Drummond et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Recent Advances in Lentiviral Vector Development and Applications
Janka Matrai et al.
MOLECULAR THERAPY (2010)
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta et al.
NATURE (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma
Michiro Susa et al.
PLOS ONE (2010)
Targeting of SMAD5 links microRNA-155 to the TGF-β pathway and lymphomagenesis
Deepak Rai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Lipidic Systems for In Vivo siRNA Delivery
Sherry Y. Wu et al.
AAPS JOURNAL (2009)
RNA regulation of epigenetic processes
John S. Mattick et al.
BIOESSAYS (2009)
被撤回的出版物: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis (Retracted article. See vol. 161, pg. 417, 2015)
Scott Valastyan et al.
CELL (2009)
Nanocarriers in Ocular Drug Delivery: An Update Review
Sheetu Wadhwa et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Polymeric nanoparticles for siRNA delivery and gene silencing
Yogesh Patil et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Off-target effects of siRNA specific for GFP
Cordula Tschuch et al.
BMC MOLECULAR BIOLOGY (2008)
Overcoming the innate immune response to small interfering RNA
Adam Judge et al.
HUMAN GENE THERAPY (2008)
Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma
Yigang Wang et al.
JOURNAL OF GENE MEDICINE (2008)
A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth
Lee M. Greenberger et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Endogenous human microRNAs that suppress breast cancer metastasis
Sohail F. Tavazoie et al.
NATURE (2008)
Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors
Keith Woods et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan - a review
Meera George et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
James O. McNamara et al.
NATURE BIOTECHNOLOGY (2006)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets
A Birmingham et al.
NATURE METHODS (2006)
Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo
AD Judge et al.
MOLECULAR THERAPY (2006)
Rapid alteration of microRNA levels by histone deacetylase inhibition
GK Scott et al.
CANCER RESEARCH (2006)
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster
Michael Dews et al.
NATURE GENETICS (2006)
A minicircuitry comprised of MicroRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis
F Fazi et al.
CELL (2005)
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
GA Calin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
DV Morrissey et al.
NATURE BIOTECHNOLOGY (2005)
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
AD Judge et al.
NATURE BIOTECHNOLOGY (2005)
siRNA-mediated off-target gene silencing triggered by a 7 nt complementation
XY Lin et al.
NUCLEIC ACIDS RESEARCH (2005)
PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase
F Leenders et al.
EMBO JOURNAL (2004)
RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia
HB Xia et al.
NATURE MEDICINE (2004)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
siRNA function in RNAi: A chemical modification analysis
YL Chiu et al.
RNA (2003)
Expression profiling reveals off-target gene regulation by RNAi
AL Jackson et al.
NATURE BIOTECHNOLOGY (2003)
Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells
XQ Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Small interfering RNA inhibits hepatitis B virus replication in mice
H Giladi et al.
MOLECULAR THERAPY (2003)
In vivo characteristics of cationic liposomes as delivery vectors for gene therapy
SAL Audouy et al.
PHARMACEUTICAL RESEARCH (2002)
Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells
XG Li et al.
CANCER GENE THERAPY (2001)
Share Paper
